Jama-Journal of the American Medical Association最新文献

筛选
英文 中文
Genomic Characterization of RSV in the US by Vaccination Status. 美国RSV疫苗接种状况的基因组特征
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-05-06 DOI: 10.1001/jama.2025.1225
Adam S Lauring, Connor Edson, Diya Surie, Fatimah S Dawood, Wesley H Self, Cynthia Lucero-Obusan, Mark Holodniy
{"title":"Genomic Characterization of RSV in the US by Vaccination Status.","authors":"Adam S Lauring, Connor Edson, Diya Surie, Fatimah S Dawood, Wesley H Self, Cynthia Lucero-Obusan, Mark Holodniy","doi":"10.1001/jama.2025.1225","DOIUrl":"10.1001/jama.2025.1225","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1540-1543"},"PeriodicalIF":63.1,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143588247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dialysis-Reply. 透析-回复。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-05-06 DOI: 10.1001/jama.2025.0282
Jennifer E Flythe
{"title":"Dialysis-Reply.","authors":"Jennifer E Flythe","doi":"10.1001/jama.2025.0282","DOIUrl":"10.1001/jama.2025.0282","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1546"},"PeriodicalIF":63.1,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143765953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Negotiating With Patients About Tests, Referrals, and Treatments. 与病人就检查、转诊和治疗进行协商。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-05-06 DOI: 10.1001/jama.2025.0858
Richard L Kravitz
{"title":"Negotiating With Patients About Tests, Referrals, and Treatments.","authors":"Richard L Kravitz","doi":"10.1001/jama.2025.0858","DOIUrl":"10.1001/jama.2025.0858","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1538-1539"},"PeriodicalIF":63.1,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143659722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allusion and Memory-Poetry as "Neuroscience". 典故与记忆——作为“神经科学”的诗歌。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-05-06 DOI: 10.1001/jama.2025.0464
Rafael Campo
{"title":"Allusion and Memory-Poetry as \"Neuroscience\".","authors":"Rafael Campo","doi":"10.1001/jama.2025.0464","DOIUrl":"10.1001/jama.2025.0464","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1551"},"PeriodicalIF":63.1,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143813023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence Supports Breastfeeding Interventions in Primary Care, but Implementation Is Still Challenging. 证据支持母乳喂养干预在初级保健,但实施仍然具有挑战性。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-05-06 DOI: 10.1001/jama.2025.4796
Jill R Demirci, Katherine Standish, Ifeyinwa V Asiodu
{"title":"Evidence Supports Breastfeeding Interventions in Primary Care, but Implementation Is Still Challenging.","authors":"Jill R Demirci, Katherine Standish, Ifeyinwa V Asiodu","doi":"10.1001/jama.2025.4796","DOIUrl":"10.1001/jama.2025.4796","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1495-1497"},"PeriodicalIF":63.1,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143804895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostate Cancer: A Review. 前列腺癌:综述。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.0228
Ruben Raychaudhuri, Daniel W Lin, R Bruce Montgomery
{"title":"Prostate Cancer: A Review.","authors":"Ruben Raychaudhuri, Daniel W Lin, R Bruce Montgomery","doi":"10.1001/jama.2025.0228","DOIUrl":"10.1001/jama.2025.0228","url":null,"abstract":"<p><strong>Importance: </strong>Prostate cancer is the most common nonskin cancer in men in the US, with an estimated 299 010 new cases and 35 250 deaths in 2024. Prostate cancer is the second most common cancer in men worldwide, with 1 466 680 new cases and 396 792 deaths in 2022.</p><p><strong>Observations: </strong>The most common type of prostate cancer is adenocarcinoma (≥99%), and the median age at diagnosis is 67 years. More than 50% of prostate cancer risk is attributable to genetic factors; older age and Black race (annual incidence rate, 173.0 cases per 100 000 Black men vs 97.1 cases per 100 000 White men) are also strong risk factors. Recent guidelines encourage shared decision-making for prostate-specific antigen (PSA) screening. At diagnosis, approximately 75% of patients have cancer localized to the prostate, which is associated with a 5-year survival rate of nearly 100%. Based on risk stratification that incorporates life expectancy, tumor grade (Gleason score), tumor size, and PSA level, one-third of patients with localized prostate cancer are appropriate for active surveillance with serial PSA measurements, prostate biopsies, or magnetic resonance imaging, and initiation of treatment if the Gleason score or tumor stage increases. For patients with higher-risk disease, radiation therapy or radical prostatectomy are reasonable options; treatment decision-making should include consideration of adverse events and comorbidities. Despite definitive therapy, 2% to 56% of men with localized disease develop distant metastases, depending on tumor risk factors. At presentation, approximately 14% of patients have metastases to regional lymph nodes. An additional 10% of men have distant metastases that are associated with a 5-year survival rate of 37%. Treatment of metastatic prostate cancer primarily relies on androgen deprivation therapy, most commonly through medical castration with gonadotropin-releasing hormone agonists. For patients with newly diagnosed metastatic prostate cancer, the addition of androgen receptor pathway inhibitors (eg, darolutamide, abiraterone) improves survival. Use of abiraterone improved the median overall survival from 36.5 months to 53.3 months (hazard ratio, 0.66 [95% CI, 0.56-0.78]) compared with medical castration alone. Chemotherapy (docetaxel) may be considered, especially for patients with more extensive disease.</p><p><strong>Conclusions and relevance: </strong>Approximately 1.5 million new cases of prostate cancer are diagnosed annually worldwide. Approximately 75% of patients present with cancer localized to the prostate, which is associated with a 5-year survival rate of nearly 100%. Management includes active surveillance, prostatectomy, or radiation therapy, depending on risk of progression. Approximately 10% of patients present with metastatic prostate cancer, which has a 5-year survival rate of 37%. First-line therapies for metastatic prostate cancer include androgen deprivation and novel androgen","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1433-1446"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143588311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Blood Test Shows Promise in Detecting Pancreatic Cancer. 新的血液检测有望检测胰腺癌。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.2572
Samantha Anderer
{"title":"New Blood Test Shows Promise in Detecting Pancreatic Cancer.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.2572","DOIUrl":"10.1001/jama.2025.2572","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1385"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143674915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protein S Genomics and Proteomics Refine Thrombosis Risk. 蛋白质S基因组学和蛋白质组学可改善血栓形成风险。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.1883
Margaret V Ragni
{"title":"Protein S Genomics and Proteomics Refine Thrombosis Risk.","authors":"Margaret V Ragni","doi":"10.1001/jama.2025.1883","DOIUrl":"10.1001/jama.2025.1883","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1401-1402"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulse Oximetry and Skin Pigmentation-New Guidance From the FDA. 脉搏血氧仪和皮肤色素——FDA的新指南。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.1959
Michael S Lipnick, Odinakachukwu Ehie, Elizabeth N Igaga, Philip Bicker
{"title":"Pulse Oximetry and Skin Pigmentation-New Guidance From the FDA.","authors":"Michael S Lipnick, Odinakachukwu Ehie, Elizabeth N Igaga, Philip Bicker","doi":"10.1001/jama.2025.1959","DOIUrl":"10.1001/jama.2025.1959","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1393-1395"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143568923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How AI Could Improve Health Care for People With Intellectual and Developmental Disabilities. 人工智能如何改善智力和发育障碍者的医疗保健。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.2552
Yulin Hswen, Nora Collins
{"title":"How AI Could Improve Health Care for People With Intellectual and Developmental Disabilities.","authors":"Yulin Hswen, Nora Collins","doi":"10.1001/jama.2025.2552","DOIUrl":"10.1001/jama.2025.2552","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1377-1379"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143674907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信